Metabolic disposition of the anti-cancer agent [(14)C]laromustine in male rats

由 Nassar, Ala F., Wisnewski, Adam, King, Ivan
發表在 Xenobiotica (2015)

Impact of recent innovations in the use of mass cytometry in support of drug development

由 Nassar, Ala F., Ogura, Hideki, Wisnewski, Adam V.
發表在 Drug Discov Today (2015)

Automation of sample preparation for mass cytometry barcoding in support of clinical research: protocol optimization

由 Nassar, Ala F., Wisnewski, Adam V., Raddassi, Khadir
發表在 Anal Bioanal Chem (2017)

LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2’ and 2,4’ vs. 4,4’) of Methylene Diphenyl-Diisocyanate

由 Wisnewski, Adam V, Liu, Jian, Nassar, Ala F
發表在 EC Pharmacol Toxicol (2019)

Di-Lysine-Methylene Diphenyl Diisocyanate (MDI), a Urine Biomarker of MDI Exposure?

由 Wisnewski, Adam V., Nassar, Ala F, Liu, Jian, Bello, Dhimiter
發表在 Chem Res Toxicol (2019)

UPLC–MS for metabolomics: a giant step forward in support of pharmaceutical research

由 Nassar, Ala F., Wu, Terence, Nassar, Samuel F., Wisnewski, Adam V.
發表在 Drug Discov Today (2016)

Polymerization of hexamethylene diisocyanate in solution and a 260.23 m/z [M+H](+) ion in exposed human cells

由 Wisnewski, Adam V, Liu, Jian, Redlich, Carrie A, Nassar, Ala F
發表在 Anal Biochem (2017)

Reaction products of hexamethylene diisocyanate vapors with “self” molecules in the airways of rabbits exposed via tracheostomy

由 Wisnewski, Adam V., Kanyo, Jean, Asher, Jennifer, Goodrich, James A., Barnett, Grace, Patrylak, Lyn, Liu, Jian, Redlich, Carrie A., Nassar, Ala F.
發表在 Xenobiotica (2017)